154 related articles for article (PubMed ID: 2413480)
1. Pharmacologic manipulation of fetal hemoglobin synthesis.
Dover GJ; Humphries RK; Young N; Ley T; Boyer S; Charache S; Nienhuis A
Prog Clin Biol Res; 1985; 191():447-54. PubMed ID: 2413480
[TBL] [Abstract][Full Text] [Related]
2. Increasing fetal hemoglobin production in sickle cell disease: results of clinical trials.
Dover GJ; Charache S
Prog Clin Biol Res; 1987; 251():455-66. PubMed ID: 2448813
[TBL] [Abstract][Full Text] [Related]
3. Spectrum of fetal hemoglobin responses in sickle cell patients treated with hydroxyurea: the National Institutes of Health experience.
Rodgers GP
Semin Oncol; 1992 Jun; 19(3 Suppl 9):67-73. PubMed ID: 1379375
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic induction of fetal hemoglobin synthesis: cellular and molecular mechanisms.
Yang YM; Pace B
Pediatr Pathol Mol Med; 2001; 20(1):87-106. PubMed ID: 12673846
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults.
Charache S
Semin Hematol; 1997 Jul; 34(3 Suppl 3):15-21. PubMed ID: 9317197
[TBL] [Abstract][Full Text] [Related]
6. Concordant fetal hemoglobin response to hydroxyurea in siblings with sickle cell disease.
Steinberg MH; Voskaridou E; Kutlar A; Loukopoulos D; Koshy M; Ballas SK; Castro O; Barton F
Am J Hematol; 2003 Feb; 72(2):121-6. PubMed ID: 12555216
[TBL] [Abstract][Full Text] [Related]
7. 5-Azacytidine increases fetal hemoglobin production in a patient with sickle cell disease.
Dover GJ; Charache SH; Boyer SH; Talbot CC; Smith KD
Prog Clin Biol Res; 1983; 134():475-88. PubMed ID: 6198661
[TBL] [Abstract][Full Text] [Related]
8. Determinants of fetal hemoglobin response to hydroxyurea.
Steinberg MH
Semin Hematol; 1997 Jul; 34(3 Suppl 3):8-14. PubMed ID: 9317196
[TBL] [Abstract][Full Text] [Related]
9. Influence of cell cycle phase-specific agents on simian fetal hemoglobin synthesis.
Letvin NL; Linch DC; Beardsley GP; McIntyre KW; Miller BA; Nathan DG
J Clin Invest; 1985 Jun; 75(6):1999-2005. PubMed ID: 2409112
[TBL] [Abstract][Full Text] [Related]
10. Therapies to increase fetal hemoglobin in sickle cell disease.
Steinberg MH
Curr Hematol Rep; 2003 Mar; 2(2):95-101. PubMed ID: 12901139
[TBL] [Abstract][Full Text] [Related]
11. Fetal hemoglobin, sickling, and sickle cell disease.
Charache S
Adv Pediatr; 1990; 37():1-31. PubMed ID: 1702260
[TBL] [Abstract][Full Text] [Related]
12. Effects of rapamycin on accumulation of alpha-, beta- and gamma-globin mRNAs in erythroid precursor cells from beta-thalassaemia patients.
Fibach E; Bianchi N; Borgatti M; Zuccato C; Finotti A; Lampronti I; Prus E; Mischiati C; Gambari R
Eur J Haematol; 2006 Nov; 77(5):437-41. PubMed ID: 16939628
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological induction of fetal hemoglobin: Why haven't we been more successful in thalassemia?
Fathallah H; Sutton M; Atweh GF
Ann N Y Acad Sci; 2005; 1054():228-37. PubMed ID: 16339670
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic stimulation of Hb F in patients with sickle cell anemia.
Galanello R; Veith R; Papayannopoulou T; Stamatoyannopoulos G
Prog Clin Biol Res; 1985; 191():433-45. PubMed ID: 2413479
[No Abstract] [Full Text] [Related]
15. 2-deoxy 5-azacytidine and fetal hemoglobin induction in sickle cell anemia.
Koshy M; Dorn L; Bressler L; Molokie R; Lavelle D; Talischy N; Hoffman R; van Overveld W; DeSimone J
Blood; 2000 Oct; 96(7):2379-84. PubMed ID: 11001887
[TBL] [Abstract][Full Text] [Related]
16. Induction of hemoglobin F synthesis in patients with beta thalassemia.
Ley TJ; Nienhuis AW
Annu Rev Med; 1985; 36():485-98. PubMed ID: 2581500
[TBL] [Abstract][Full Text] [Related]
17. Combined effects of arginine and hydroxyurea on BFU-E derived colony growth and HbF synthesis in erythroid progenitors isolated from sickle cell blood.
Baliga BS; Haynes J; Obiako B; Mishra N
Cell Mol Biol (Noisy-le-grand); 2010 Jun; 56 Suppl():OL1290-8. PubMed ID: 20937216
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiologically based drug treatment of sickle cell disease.
Steinberg MH
Trends Pharmacol Sci; 2006 Apr; 27(4):204-10. PubMed ID: 16530854
[TBL] [Abstract][Full Text] [Related]
19. DNA hypomethylation therapy for hemoglobin disorders: molecular mechanisms and clinical applications.
Fathallah H; Atweh GF
Blood Rev; 2006 Jul; 20(4):227-34. PubMed ID: 16513230
[TBL] [Abstract][Full Text] [Related]
20. Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype.
Italia K; Jain D; Gattani S; Jijina F; Nadkarni A; Sawant P; Nair S; Mohanty D; Ghosh K; Colah R
Blood Cells Mol Dis; 2009; 42(1):25-31. PubMed ID: 18954999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
